A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

OBJECTIVE: Fimasartan, an angiotensin II type 1 receptor blocker, and linagliptin, a dipeptidyl-peptidase-4 inhibitor, are frequently coadministered to treat patients with hypertension and diabetes, respectively. This study sought to evaluate the pharmacokinetic interactions between fimasartan and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Woo Youl, Lee, Hae Won, Gwon, Mi-Ri, Cho, Seungil, Shim, Wang-Seob, Lee, Kyung-Tae, Yang, Dong Heon, Seong, Sook Jin, Yoon, Young-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266304/
https://www.ncbi.nlm.nih.gov/pubmed/32546973
http://dx.doi.org/10.2147/DDDT.S248205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266304/
https://www.ncbi.nlm.nih.gov/pubmed/32546973
http://dx.doi.org/10.2147/DDDT.S248205

Ejemplares similares